Liquid chromatography–tandem mass spectrometry (LC–MS/MS) reveals distinct sphingolipid patterns in anorexia and obesity.
|Articles|August 1, 2008
- LCGC North America-08-01-2008
- Volume 26
- Issue 8
Restek ESOP Transition
Restek Corporation (Bellefonte, Pennsylvania), has announced its anticipated January 1, 2009 transition from 22% to 100% employee ownership under an ESOP structure.
Advertisement
Restek Corporation (Bellefonte, Pennsylvania), has announced its anticipated January 1, 2009 transition from 22% to 100% employee ownership under an ESOP structure. The company has been planning for and testing employee ownership models since its inception in 1985. As part of the transaction, Restek's Performance Coatings "RPC" division will become an independent company led by Paul Silvis and members of the RPC team.
Articles in this issue
over 18 years ago
Highlights of HPLC 2008: Part Iover 18 years ago
Researchers Develop New Method for Drug Testingover 18 years ago
A Mass Spectrometry Primer: Part Iover 18 years ago
Indiaover 18 years ago
Column Careover 18 years ago
Horizon Technology Partners with World Water Monitoring Dayover 18 years ago
Linear Thinking in a Nonlinear Worldover 18 years ago
Phenomenex Expands NetworkAdvertisement
Related to this article
Leon Niezen and Gert Desmet discuss uncertainty-driven LC method development, peak overlap, and moving from in silico to real data.
Leon Niezen and Gert Desmet describe how predictive uncertainty can make automated LC method development more reliable.
Liquid chromatography–mass spectrometry (LC–MS) serum profiling ties lysine compounds to lupus kidney disease.
Liquid chromatography-mass spectrometry (LC–MS) growth lifts Waters Q3; MOBILion ion mobility buy expands proteomics.
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) measures galactose-1-phosphate in dried blood spots to monitor galactosemia.
Sam Whitmarsh explores how retention-time models handle interlaboratory data, novel chemotypes, unusual phases and ionisable compounds, and what labs need to do to build useful in-house models.
Advertisement
Advertisement
Trending on LCGC International
1
AI/ML Now: Toxicity Prediction for Unknown LC–HRMS Features Using Machine Learning
2
LCGC Blog: Building a Career Series That Goes Beyond the Surface
3
Industry Roundup: Waters Posts Strong Third Quarter as LC–MS and Chromatography Consumables Drive Growth, Acquires Ion Mobility Pioneer MOBILion
4
From 9000 Clues to a Clinical Test: Mass Spectrometry-Driven Lipidomics for Early Cancer Detection
5